264 related articles for article (PubMed ID: 31439598)
1. A systematic review of methodological quality of model development studies predicting prognostic outcome for resectable pancreatic cancer.
Bradley A; Van Der Meer R; McKay CJ
BMJ Open; 2019 Aug; 9(8):e027192. PubMed ID: 31439598
[TBL] [Abstract][Full Text] [Related]
2. Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.
Moriarty AS; Meader N; Snell KI; Riley RD; Paton LW; Chew-Graham CA; Gilbody S; Churchill R; Phillips RS; Ali S; McMillan D
Cochrane Database Syst Rev; 2021 May; 5(5):CD013491. PubMed ID: 33956992
[TBL] [Abstract][Full Text] [Related]
3. A prognostic Bayesian network that makes personalized predictions of poor prognostic outcome post resection of pancreatic ductal adenocarcinoma.
Bradley A; Van der Meer R; McKay CJ
PLoS One; 2019; 14(9):e0222270. PubMed ID: 31498836
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract][Full Text] [Related]
5. Prognostic models to predict survival in patients with pancreatic cancer: a systematic review.
Ioannou LJ; Maharaj AD; Zalcberg JR; Loughnan JT; Croagh DG; Pilgrim CH; Goldstein D; Kench JG; Merrett ND; Earnest A; Burmeister EA; White K; Neale RE; Evans SM
HPB (Oxford); 2022 Aug; 24(8):1201-1216. PubMed ID: 35289282
[TBL] [Abstract][Full Text] [Related]
6. Surgery for epilepsy.
West S; Nevitt SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010541. PubMed ID: 31237346
[TBL] [Abstract][Full Text] [Related]
7. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
9. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer.
Strijker M; Chen JW; Mungroop TH; Jamieson NB; van Eijck CH; Steyerberg EW; Wilmink JW; Groot Koerkamp B; van Laarhoven HW; Besselink MG
Br J Surg; 2019 Mar; 106(4):342-354. PubMed ID: 30758855
[TBL] [Abstract][Full Text] [Related]
11. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
12. Prognostic models for patients suffering a heart failure with a preserved ejection fraction: a systematic review.
Jia YY; Cui NQ; Jia TT; Song JP
ESC Heart Fail; 2024 Jun; 11(3):1341-1351. PubMed ID: 38318693
[TBL] [Abstract][Full Text] [Related]
13. Outcome prediction models incorporating clinical variables for Head and Neck Squamous cell Carcinoma: A systematic review of methodological conduct and risk of bias.
Aly F; Hansen CR; Al Mouiee D; Sundaresan P; Haidar A; Vinod S; Holloway L
Radiother Oncol; 2023 Jun; 183():109629. PubMed ID: 36934895
[TBL] [Abstract][Full Text] [Related]
14. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
[TBL] [Abstract][Full Text] [Related]
15. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
16. Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol.
Deliu N; Cottone F; Collins GS; Anota A; Efficace F
BMJ Open; 2018 Oct; 8(10):e025054. PubMed ID: 30361409
[TBL] [Abstract][Full Text] [Related]
17. Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review.
Dhiman P; Ma J; Andaur Navarro CL; Speich B; Bullock G; Damen JAA; Hooft L; Kirtley S; Riley RD; Van Calster B; Moons KGM; Collins GS
BMC Med Res Methodol; 2022 Apr; 22(1):101. PubMed ID: 35395724
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
19. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study.
Aziz MH; Sideras K; Aziz NA; Mauff K; Haen R; Roos D; Saida L; Suker M; van der Harst E; Mieog JS; Bonsing BA; Klaver Y; Koerkamp BG; van Eijck CH
Ann Surg; 2019 Jul; 270(1):139-146. PubMed ID: 29334554
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks?
Gao Y; Cheng S; Zhu L; Wang Q; Deng W; Sun Z; Wang S; Xue H
Eur Radiol; 2022 Dec; 32(12):8443-8452. PubMed ID: 35904618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
